CAT

946.5

+1.47%↑

GE

351.65

+2.81%↑

GEV.US

981.84

+0.35%↑

RTX

186.53

+1.7%↑

BA

227.42

-0.75%↓

CAT

946.5

+1.47%↑

GE

351.65

+2.81%↑

GEV.US

981.84

+0.35%↑

RTX

186.53

+1.7%↑

BA

227.42

-0.75%↓

CAT

946.5

+1.47%↑

GE

351.65

+2.81%↑

GEV.US

981.84

+0.35%↑

RTX

186.53

+1.7%↑

BA

227.42

-0.75%↓

CAT

946.5

+1.47%↑

GE

351.65

+2.81%↑

GEV.US

981.84

+0.35%↑

RTX

186.53

+1.7%↑

BA

227.42

-0.75%↓

CAT

946.5

+1.47%↑

GE

351.65

+2.81%↑

GEV.US

981.84

+0.35%↑

RTX

186.53

+1.7%↑

BA

227.42

-0.75%↓

Search

CryoPort Inc

Atvērts

SektorsRūpniecība

14.7 -0.61

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

14.53

Max

14.92

Galvenie mērījumi

By Trading Economics

Ienākumi

14M

-9.4M

Pārdošana

2.3M

48M

EPS

-0.19

Peļņas marža

-19.733

Darbinieki

684

EBITDA

443K

-3.2M

Dividendes

By Acuity

Nākamie ieņēmumi

2026. g. 4. aug.

Tirgus statistika

By TradingEconomics

Tirgus kapitalizācija

259M

780M

Iepriekšējā atvēršanas cena

15.31

Iepriekšējā slēgšanas cena

14.7

Ziņu noskaņojums

By Acuity

50%

50%

193 / 404 Rangs Industrials

CryoPort Inc Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Par CryoPort Inc

Cryoport, Inc. provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and human reproductive medicine markets in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers Cryoport Express Shippers; Cryoport ELITE -80°C Gene Therapy Shipper; Cryoport ELITE Cryosphere Shipper; Cryoport consulting services, including physical, thermal, and shipping qualifications of shipping systems and/or packaging to developing custom packaging solutions; and Cryoport bioservices, such as controlled temperature storage, fulfilment, kit production, secondary packaging, labelling of therapeutic products, and GMP raw materials storage services. It also provides CRYOGENE, an unparalleled solution that offers pre-clinical temperature-controlled biological materials management services comprising specimen storage, processing, collection, and retrieval; CRYOPD, a temperature-controlled logistics solution, which include temperature-controlled packaging and transport solutions from cryogenic temperature to controlled ambient; and IntegriCell services that comprise apheresis/leukapheresis collection, Cryoshuttle transportation, cryo-process optimization and processing services. In addition, the company offers MVE Biological Solutions' Fusion cryogenic system, a self-sustaining cryogenic freezer; MVE Biological Solutions' Vario cryogenic system, a cryogenic freezer system that supports temperatures between -20°C and -150°C; Cryoport Cryoshuttle provides clients with dedicated local transportation support; and Tec4Med. Further, it provides biological specimen cryopreservation storage and maintenance; archiving, monitoring, tracking, receipt, and delivery of samples; frozen biological specimens transportation; and incoming and outgoing biological specimens management; and short-term logistics and engineering consulting services. Cryoport, Inc. was founded in 1999 and is headquartered in Brentwood, Tennessee.
help-icon Live chat